Data Quality

Know where every number came from, and how much to trust it

Sleuth checks every value from 150 million+ documents as they come in, links it to its drug, trial, or company, and scores its sourcing. You see where each number came from and the handful to check.

Sleuth scores every value and shows you the few worth checking

Sleuth scores every value in a dataset with the same rules: how good its best source is, whether independent sources agree, and, where it matters, how recent it is. Most score high, and you can trust them. Review mode puts the low scores in front of you, so you can check each one.

The groundwork is done before you ask

Ask Claude on its own and it rebuilds the landscape from a web search every time. Sleuth has already matched every trial, drug, company, and deal to one record and linked them, so your answer starts from that work.

pembrolizumabenfortumab vedotinMerckMerck Sharp & Dohme LLCBladder cancerMuscle-invasive86.1%KEYNOTE-B15 / EV-304NCT04700124

63%

more of the landscape found with Sleuth connected, on average across 15 tests

+55%

Claude

Alone

With Sleuth

+27%

ChatGPT

Alone

With Sleuth

+108%

Perplexity

Alone

With Sleuth

The hard parts of biopharma data, handled as it comes in

Sleuth takes in new documents every day and runs each one through the same matching and checks before it reaches your datasets, so the knowledge base stays clean and current.

One drug, about 150 spellings

MK-3475, lambrolizumab, and Keytruda are all pembrolizumab. Every code name, old name, and typo resolves to one record.

Two registries, two answers

When ClinicalTrials.gov and China’s registry disagree about a trial, Sleuth keeps both sources and shows you the conflict in Review mode.

Three numbers in one abstract

An abstract reports the result, the comparison arm, and the hazard ratio. Sleuth’s knowledge base knows the difference, and pulls what’s relevant.

One disease, many levels

Lung adenocarcinoma sits under NSCLC, which sits under lung cancer. Ask about lung cancer, and the narrower programs show up.

The program that quietly disappears

Sleuth keeps earlier versions of company pipeline pages, so a program dropped without a press release shows up as a change, not a silence.

Old news that looks current

Every value is dated. Where recency matters, a status last updated years ago scores lower than one updated this month.

“The genetic basis is always the thing that takes the longest, and the public data on it is often wishy-washy. Sleuth told us how sure we could be about every value, with the reasoning and the sources. It made it easy to find what I needed, and to know what to double-check before anything went to our board.”

Dr. John Lambourne

Gene editing lead, Pencil Biosciences

The values to review stand out at a glance

Review first

Values Sleuth flagged for conflicting sources or thin evidence, where John’s expertise mattered most

Use as is

Well-sourced values John could use without a deep review

Enterprise

The same quality for your own knowledge

On Enterprise, your documents and data go into the knowledge base next to Sleuth’s, held to the same standard and kept private.

Your data, through the same steps

Bring in documents and data from Drive, SharePoint, Box, or your warehouse. Sleuth matches your internal program names to the same records and checks them the same way, so your programs show up in the same tables as everyone else’s.

Your data stays yours

Sleuth has a SOC 2 Type II report and encrypts your data in transit and at rest. Your company’s questions, documents, and results are never shown in anyone else’s work. A single-tenant option gives you your own environment.

See Sleuth for Enterprise

Review the data behind your question

Set up in Claude, ChatGPT, or Copilot